BioSpace News Archive

InventisBio (Shanghai) (hereinafter referred to as “InventisBio”) announced today that it has signed a “Collaboration Agreement” with Betta Pharma (hereinafter referred to as “Betta Pharma”)

Future Market Insights foresees significant growth opportunities in hydrocephalus shunt market, considering the new-age development of smart shunt technology, while delivering advance diagnosis of cerebrospinal fluid (CSF), control, and communication, on the basis of sensors, telemetry, and feedback controls.

Rosen Law Firm reminds purchasers of the securities of India Globalization Capital, Inc. from October 25, 2017 through October 29, 2018, inclusive (the “Class Period”) of the January 2, 2019 lead plaintiff deadline in the first filed class action commenced by the Rosen Firm.

Largest dental support organization increases intraoral scanner awareness with first-annual event

Regional Health Properties, Inc. announced today that, at Regional’s 2018 Annual Meeting of Shareholders held on December 27, 2018 (the “Annual Meeting”), Regional’s shareholders approved a proposal to amend Regional’s Articles of Incorporation to effect a reverse stock split of Regional’s common stock at a ratio of between one-for-six and one-for-twelve, as determined by Regional’s Board of Directors in its sole discretion.

Dental Center of Northwest Ohio (the “Dental Center”) is providing notice to current and former patients and employees of a recent incident involving personal information.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into AxoGen, Inc. (NasdaqCM: AXGN).

PolarityTE, Inc. (Nasdaq: PTE), a commercial-stage biotechnology company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences, today announced that it registered OsteoTE™ with the U.S. Food and Drug Administration (FDA) pursuant to applicable regulations governing human cells, tissues and cellular and tissue-based products (HCT/Ps).

Zoetis Inc. will host a webcast and conference call at 8:30 a.m. on Thursday, Feb. 14, 2019.

The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country.